| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | -$201K | -7.45K | -3.73% | $26.98 | 192K | Feb 1, 2023 | By LLC | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | -$66.9K | -2.48K | -2.54% | $26.98 | 95.3K | Feb 1, 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F2, F4 |
| transaction | CSTL | Common Stock | Sale | -$67K | -2.48K | -2.54% | $26.98 | 95.3K | Feb 1, 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F2, F5 |
| transaction | CSTL | Common Stock | Sale | -$122K | -4.45K | -2.32% | $27.51 | 188K | Feb 1, 2023 | By LLC | F1, F3, F6 |
| transaction | CSTL | Common Stock | Sale | -$40.8K | -1.48K | -1.56% | $27.51 | 93.8K | Feb 1, 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F6 |
| transaction | CSTL | Common Stock | Sale | -$40.8K | -1.48K | -1.56% | $27.51 | 93.8K | Feb 1, 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F6 |
| transaction | CSTL | Common Stock | Sale | -$76.6K | -2.68K | -1.43% | $28.55 | 185K | Feb 2, 2023 | By LLC | F1, F3, F7 |
| transaction | CSTL | Common Stock | Sale | -$25.6K | -895 | -0.95% | $28.55 | 92.9K | Feb 2, 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F7 |
| transaction | CSTL | Common Stock | Sale | -$25.6K | -895 | -0.95% | $28.55 | 92.9K | Feb 2, 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F7 |
| transaction | CSTL | Common Stock | Sale | -$12.2K | -420 | -0.23% | $29.12 | 185K | Feb 2, 2023 | By LLC | F1, F3, F8 |
| transaction | CSTL | Common Stock | Sale | -$4.08K | -140 | -0.15% | $29.12 | 92.8K | Feb 2, 2023 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F8 |
| transaction | CSTL | Common Stock | Sale | -$4.08K | -140 | -0.15% | $29.12 | 92.8K | Feb 2, 2023 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F8 |
| holding | CSTL | Common Stock | 830 | Feb 1, 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on November 23, 2022. |
| F2 | This transaction was executed in multiple trades at prices ranging from $26.320 to $27.315, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F5 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F6 | This transaction was executed in multiple trades at prices ranging from $27.320 to $27.905, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $28.100 to $29.035, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $29.105 to $29.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |